News
Perigord becomes the most certified supplier of artwork solutions to the Life Science industry
Perigord confirms, that in achieving its latest certification ISO 27001, that they are the only Global provider of Artwork Management Systems (AMS) to the...
Press Releases
LANXESS disinfectant kills coronavirus SARS-CoV-2 in just 60 seconds
Rely+On Virkon broad spectrum disinfectant, produced by specialty Chemicals Company LANXESS, demonstrates extremely rapid efficacy against the SARS-CoV-2 virus.
This is the finding of a...
News
Clinerion protects security of Patient Network Explorer user accounts with 2-step authentication
The “Clinerion PNEx Authenticator” app gives users of Clinerion’s Patient Network Explorer additional data security with 2-step authentication.
To protect Patient Network Explorer user accounts...
Drug Research
Evotec and Novo Nordisk form strategic alliance to develop novel therapies for kidney diseases
Evotec SE and Novo Nordisk announced a strategic collaboration on the discovery and development of innovative therapeutics for patients with chronic kidney disease.
Evotec and...
News
BMS and Dragonfly Therapeutics Announce Exclusive Global License for Dragonfly’s IL-12 Investigational Immunotherapy Program
Bristol Myers Squibb and Dragonfly Therapeutics, Inc. announced that they have entered into a definitive agreement under which Bristol Myers Squibb will be granted...
Drug Research
Gilead Sciences and Tango Therapeutics to Expand Strategic Oncology Collaboration
Gilead Sciences, Inc. and Tango Therapeutics announced an expanded strategic collaboration focused on the discovery, development and commercialization of innovative targeted immune evasion therapies...
Clinical Trials
Qu Biologics Initiates Phase 2 Study to Assess Activation of Anti-cancer Immune Response in Colon Cancer
Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read